Gregory O. Anglum, SVP & CFO at Bioventus Inc. (BVS), sold 1,294 shares at $11.99 ($16K) on 2022-02-14, disclosed to the SEC on 2022-02-15.
Scheduled sale ($16k) by SVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.